Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors

Laboratory Investigation

Volumn 75, Issue 5, 1996, Pages 647-657

  Weninger, Wolfgang ^a   Uthman, Aumaid ^a   Pammer, Johannes ^b   Pichler, Andrea ^a   Ballaun, Claudia ^a   Lang, Irene M ^b   Plettenberg, Andreas ^a   Bankl, Hans C ^b   Stürzl, Michael ^c   Tschachler, Erwin ^a,d  

^a Universitatsklinik fur Dermatologie   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d Ctr Rech d'Investigations E   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; KERATINOCYTE; KERATOACANTHOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEBORRHEIC KERATOSIS; SKIN CANCER; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS;

BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; HAIR FOLLICLE; HUMANS; LYMPHOKINES; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; SKIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 10544234194     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Ballaun C, Weninger W, Uthman A, Weich H, and Tschachler E (1995). Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 104:7-10.
2. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, and Dvorak HF (1993). Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53:4727-4735.
3. Brown LF, Harrist TJ, Yeo KT, Stahle-Backdahl M, Jackman RW, Berse B, Tognazzi K, Dvorak HF, and Detmar M (1995a). Increased expression of vascular permeability (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 104:744-749.
4. Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, and van de Water L (1995b). Overexpression of vascular permeability factor (VPF/ VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 154:2801-2807.
5. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, and van de Water L (1992). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176: 1375-1379.
6. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, and Nagy A (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
7. Carter DM and Lin AN (1994). Basal cell carcinoma. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, and Austen KF, editors. Dermatology in general medicine. New York: McGraw-Hill, 840-847.
8. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YCE, Olander JV, Conolly DT, and Stern D (1990). Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535-1545.
9. Conolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, and Feder J (1989). Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478.
10. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, and Dvorak HF (1994). Overexpression of vascular permeability/vascular endothelial growth factor in psoriasis. J Exp Med 180:1141-1146.
11. Detmar M, Brown LF, Dvorak HF, and Claffey KP (1995). Overexpression of VPF/VEGF in the skin of transgenic mice leads to increased skin vascularization (abstract). J Invest Dermatol 105:448.
12. Dvorak HF, Brown LF, Detmar M, and Dvorak AM (1995). Vascular permeability factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039.
13. Dvorak HF, Sioussat TM, Brown LB, Berse B, Nagy JA, Sotrel A, Manseau EJ, van de Water L, and Senger DR (1991). Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exp Med 174:1275-1278.
14. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, and Moore MW (1996). Heterocygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
15. Ferrara N and Henzel WJ (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858.
16. Ferrara N, Houck K, Jakeman L, Leung DW (1992). Molecular and biological properties of the vascular endothelial growth factor family proteins. Endocrinol Rev 13:18-32.
17. Ferrara N, Winer J, Burton T, Rowland A, Siegel M, Phillips HS, Terrell T, Keller GA, and Levinson AD (1993). Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest 91:160-170.
18. Fisher C, Angus B, and Rees J (1991). In-situ hybridization using digoxigenin-labelled probes in human skin. Br J Dermatol 125:516-520.
19. Folkman J (1995). Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1:27-31.
20. Folkman J and Shing Y (1992). Angiogenesis. J Biol Chem 267:10931-10934.
21. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, and Werner S (1995). Regulation of vascular endothelial growth factor expression in cultured keratinocytes: Implications for normal and impaired wound healing. J Biol Chem 270:12607-12613.
22. Goert S, Hagemaier H-H, and Sorg C (1994). Epidermal cytokines and endothelial cells. In: Luger TA and Schwarz T, editors. Epidermal growth factors and cytokines. New York: Marcel Dekker, 395-414.
23. Houck KS, Ferrara N, Winer J, Cachianes G, Li B, and Leung DW (1991). The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814.
24. Karelina TV, Goldberg GI, and Eisen AZ (1995). Matrix metallo-proteinases in blood vessel development in human fetal skin and in cutaneous tumors. J Invest Dermatol 105: 411-417.
25. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, and Conolly DT (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309-1312.
26. Kim KJ, Li B, Houck K, Winer J, and Ferrara N (1992). The vascular endothelial growth factor proteins: Identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 7:53-64.
27. Kim KJ, Li B, Winer J, Armanini M, Gillet N, Phillips HS, and Ferrara N (1993). Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumour growth in-vivo. Nature 362:841-844.
28. Koch AE, Harlow LA, Haines GH, Amento EP, Unemori EN, Wong WL, Pope RM, and Ferrara N (1994). Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149-4156.
29. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, and Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
30. Lever WF and Schaumburg-Lever G (1990). Histopathology of the skin. Philadelphia: JB Lippincott.
31. Millauer B, Shawver LK, Plate KH, Risau W, and Ullrich A (1994). Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant. Nature 367:576-579.
32. Miller SJ (1991). Biology of basal cell carcinoma (part I). J Am Acad Dermatol 24:1-13.
33. Minchenko A, Bauer T, Salceda S, and Caro J (1994). Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71:374-379.
34. Myoken Y, Kayada Y, Okamoto T, Kan M, Sato GH, and Sato JD (1991). Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci USA 88:5819-5823.
35. Nishiyama S (1964). Capillardarstellung durch die alkalische Phophatase-Färbung bei verschiedenen Dermatosen. VI. Epitheliale Tumoren. Hautarzt 15:175-181.
36. Obermair A, Kurz C, Czerwenka K, Thoma M, Kaider A, Wagner T, Gitsch G, and Sevelda P (1995). Microvessel density and vessel invasion in lymph-node-negative breast cancer: Effect on recurrence-free survival. Int J Cancer 62:126-131.
37. Park JE, Keller GA, and Ferrara N (1993). The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extrcellular matrix-bound VEGF. Mol Biol Cell 4:1317-1326.
38. Plate KH, Breier G, Weich HA, and Risau W (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848.
39. Plettenberg A, Ballaun C, Pammer J, Mildner M, Strunk D, Weninger W, and Tschachler E (1995). Human melanocytes and melanoma cells constitutively express the bcl-2 protooncogene in situ and in cell culture. Am J Pathol 146:651-659.
40. Plouet J, Schilling J, and Gospodarowicz D (1989). Isolation and characterization of a newly identified endothelial cell mitogen produced by At-20 cells. EMBO J 8:3801-3806.
41. Pötgens AJG, Lubsen NH, van Altena MH, Schoenmakers JGG, Ruiter DJ, and de Waal RMW (1995). Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am J Pathol 146:197-209.
42. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, and Dvorak HF (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
43. Senger DR, Perruzzi CA, Feder J, and Dvorak HF (1986). A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629-5632.
44. Shweiki D, Itin A, Soffer D, and Keshet B (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 176:843-845.
45. Stoler A, Kopan R, Duvic M, and Fuchs E (1988). Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J Cell Biol 107:427-446.
46. Tahan SR and Stein AL (1995). Angiogenesis in invasive squamous cell carcinoma of the lip: Tumor vascularity is not an indicator of metastatic risk. J Cutan Pathol 22:236-240.
47. Takahashi A, Sasaki H, Kim SJ, Tobisu KI, Kakizoe T, Tsukamoto T, Kumamoto Y, Sugimura T, and Terada M (1994). Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54:4233-4237.
48. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, and Abraham JA (1991). The human gene for vascular endothelial growth factor. J Biol Chem 266:11947-11954.
49. Tschachler E, Robert-Guroff M, Gallo RC, and Reitz MS Jr (1989). Human T-lymphotropic virus I-infected T cells constitutively express lymphotoxin in vitro. Blood 73:194-201.
50. Unemori EN, Ferrara N, Bauer EA, and Amento EP (1992). Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153:557-562.
51. Warren RS, Yuan H, Matli MR, Gillet NA, and Ferrara N (1995). Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95:1789-1797.